Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04587804
Other study ID # BTL-703_100
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 17, 2019
Est. completion date March 15, 2021

Study information

Verified date March 2021
Source BTL Industries Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will evaluate the clinical efficacy and safety of a simultaneous treatment by repetitive pulse magnetic stimulation and radiofrequency energy for toning of abdomen and reduction of subcutaneous fat. The study is a prospective multi-center open-label single-arm study. The subjects will be enrolled and assigned into a single study group. Subjects will be required to complete three (3) treatment visits and two to three follow-up visits. All of the study subjects will receive the treatment with the subject device.


Description:

This study will evaluate the clinical efficacy and safety of a simultaneous treatment by repetitive pulse magnetic stimulation and radiofrequency energy for toning of abdomen and reduction of subcutaneous fat. The study is a prospective multi-center open-label single-arm study. The subjects will be enrolled and assigned into a single study group. Subjects will be required to complete three (3) treatment visits and two to three follow-up visits. All of the study subjects will receive the treatment with the subject device. At the baseline visit MRI will be performed, subject's weight and waist circumference will be recorded. Photos of the treated area will be taken. The treatment administration phase will consist of three (3) treatments, delivered once a week. The applicator will be applied over umbilicus and visible muscle contractions along with heating of the subcutaneous fat will be induced by the device. At the last therapy visit, the subject's weight and waist circumference will be recorded, and photos of the treated area will be taken. In addition, subjects will receive Subject Satisfaction Questionnaire to fill in. Safety measures will include documentation of adverse events (AE) including subject's experience of pain or discomfort after each procedure. Following each treatment administration and at all of the follow-up visits, subjects will be checked for immediate post-procedure adverse event assessment. During the post-procedure visits (at 1-month and 3-month follow-up visits), the subjects will undergo MRI scanning. Also, subject's satisfaction will be noted and weight with waist circumference will be recorded. Photographs of the treated area will be taken. There will be an option of a 6-months follow-up visit, according to subject's availability.


Recruitment information / eligibility

Status Completed
Enrollment 41
Est. completion date March 15, 2021
Est. primary completion date June 9, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - Age = 21 years - Voluntarily signed informed consent form - BMI = 35 kg/m2 - Women of child-bearing potential are required to use birth control measures during the whole duration of the study - Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring during study participation - Subjects willing and able to maintain her regular (pre-procedure) diet and exercise regimen without affecting significant change in either direction during study participation Exclusion Criteria: - Electronic implants (such as cardiac pacemakers, defibrillators and neurostimulators) - Metal implants - Drug pumps - Malignant tumour - Pulmonary insufficiency - Injured or otherwise impaired muscles - Cardiovascular diseases - Disturbance of temperature or pain perception - Hemorrhagic conditions - Septic conditions and empyema - Acute inflammations - Systemic or local infection such as osteomyelitis and tuberculosis - Contagious skin disease - Elevated body temperature - Pregnancy, postpartum period, nursing, and menstruation - Intrauterine device (IUD) - Swollen or neoplastic tissues, space occupying lesions or skin eruptions in the treatment area - Basedow's disease

Study Design


Related Conditions & MeSH terms


Intervention

Device:
rPMS+RF
The treatment administration phase will consist of three (3) treatments, delivered once a week. The applicator of the device will be applied over umbilicus and visible muscle contractions along with heating of the subcutaneous fat will be induced by the device.

Locations

Country Name City State
United States Chicago Cosmetic Surgery and Dermatology Chicago Illinois
United States Skin Care Physicians of Georgia Macon Georgia

Sponsors (1)

Lead Sponsor Collaborator
BTL Industries Ltd.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of change in adipose and muscular layer thickness between pre-treatment and post-treatment based on MRI scans MRI will be conducted at the baseline visit and all follow-up visits. The imaging will be conducted at the same surface area each time.
Hospital-grade MRI device will be used to scan abdominal area of each subject. The MRI scan without any contrast agent will be performed, with the scanned body segment determined by vertebrae T12 and S1. Lateral cuts from 5 cm below the umbilicus and 5 cm above the umbilicus will be evaluated for the thickness of muscle and subcutaneous adipose tissue.
4 months
Primary Evaluation of change in adipose layer thickness between pre-treatment and post-treatment based on waist circumference measurements Waist circumference measure will be conducted at the baseline visit, after last treatment and during follow-up visits.
The waist circumference measure will be made at the top of the subject's iliac crest, with the tape held snugly, but not constricting, and at a level parallel to the floor. For the measurement, a stretch-resistant tape will be used.
During the measuring, subject will stand with arms at the side, feet positioned close together, and weight evenly distributed across the feet. The subject will be instructed to relax and take a few deep, natural breaths before the actual measurement is made. The subjects will be measured in underwear only, after voiding the bladder.
4 months
Secondary Evaluation of subject's satisfaction with the treatment using the Subject Satisfaction Questionnaire The 5-point Likert scale Satisfaction questionnaire will be used to evaluate the participant's satisfaction with the therapy outcome with answer "Strongly agree" being the most positive outcome and "Strongly disagree" the most negative. Subject satisfaction will be assessed after the last therapy visit and during the follow-up visits. 7 months
Secondary Safety of the device measured via the occurrence of adverse events or lack thereof The occurrence of adverse events will be followed throughout the whole study. 7 months
See also
  Status Clinical Trial Phase
Completed NCT04599257 - Fat Reduction and Muscle Toning of Thighs N/A
Completed NCT05580263 - Different Order of Concurrent Training on Improving Visceral Adipose Tissue and Insulin Resistance. N/A
Completed NCT04643275 - Effect of BTL-899 Device for Non-invasive Lipolysis on Human Upper Arms N/A
Completed NCT05139745 - Histological Evaluation of BTL-899 Device´s Effect on Fat Tissue N/A
Completed NCT05975489 - Genetics in the Effect of Caffeine on Fat Oxidation N/A
Completed NCT04621019 - BTL-785F Device for Non-invasive Lipolysis and Circumference Reduction of the Abdomen N/A
Completed NCT04696614 - Testing the Effect of Exercise Intervention Using a SMART Design. N/A
Completed NCT04455009 - Acute Effects of Fitness Drink Formulas on Energy Expenditure and Fat Metabolism N/A
Completed NCT05260164 - Effect of BTL-899 Device for Non-invasive Lipolysis on Human Flanks N/A
Recruiting NCT05261373 - Efficacy of a Nutritional Education Strategy and Physical Exercise on the Gut Microbiota in Type 2 Diabetics N/A
Recruiting NCT04043182 - EFFECTIVENESS OF ULTRASOUND FOR LOCAL FAT TREATMENT N/A
Completed NCT05540080 - Non-invasive Lipolysis and Improvement of Muscle Tone in Lateral Abdomen N/A
Completed NCT04587986 - rPMS and Radiofrequency for Abdominal Toning and Reduction of Subcutaneous Fat N/A
Active, not recruiting NCT06274177 - Evaluation of the BTL-785F Device for Submental Fat Reduction and Neck Rejuvenation N/A
Completed NCT06282172 - Histological Evaluation of BTL-785F Device's Effect on Submental Subcutaneous Adipose Tissue N/A
Not yet recruiting NCT03357601 - High Intensity Interval Training vs Moderate Continuous Endurance Exercise Training on Program Adherence N/A
Completed NCT05215275 - Comparison of Different Exercise Trainings on Heart Rate Variability N/A
Completed NCT03811093 - Comparing the Efficacy of a Dual-Frequency LLLT Device With a Sham Device as a Therapy for Adipose Tissue Loss N/A
Active, not recruiting NCT06333496 - Effect of a Glucagon Like Peptide 1 (GLP1) Booster in Healthy Humans N/A
Not yet recruiting NCT06219850 - Physical Exercise, Diet, and Health in People With Type 2 Diabetes: Longitudinal Design of the EDUGUTION Study